Home/Filings/4/0001209191-17-017407
4//SEC Filing

ACORDA THERAPEUTICS INC 4

Accession 0001209191-17-017407

CIK 0001008848operating

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:04 PM ET

Size

7.2 KB

Accession

0001209191-17-017407

Insider Transaction Report

Form 4
Period: 2017-03-01
Blight Andrew
Chief Scientifc Officer
Transactions
  • Award

    Common Stock

    2017-03-01+2,03678,594 total
  • Award

    Employee Stock Option (right to buy)

    2017-03-01+5,0905,090 total
    Exercise: $27.48Exp: 2027-03-01Common Stock (5,090 underlying)
Footnotes (2)
  • [F1]Restricted shares issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2017, December 1, 2018, December 1, 2019 and December 1, 2020.
  • [F2]The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2017 with the first quarterly installment vesting on April 1, 2017.

Issuer

ACORDA THERAPEUTICS INC

CIK 0001008848

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001008848

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:04 PM ET
Size
7.2 KB